IV tissue plasminogen activator for stroke in the community - What we know and don't know 10 years after FDA approval

被引:7
作者
Furlan, AJ [1 ]
机构
[1] Cleveland Clin, Cleveland, OH 44195 USA
关键词
stroke; acute; thrombolysis;
D O I
10.1161/01.STR.0000199853.52386.70
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:281 / 281
页数:1
相关论文
共 3 条
[1]   Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients - An analysis of the nationwide inpatient sample 1999 to 2002 [J].
Bateman, BT ;
Schumacher, HC ;
Boden-Albala, B ;
Berman, MF ;
Mohr, JP ;
Sacco, RL ;
Pile-Spellman, J .
STROKE, 2006, 37 (02) :440-446
[2]   Is in-hospital stroke mortality an accurate measure of quality of care? [J].
Hinchey, JA ;
Furlan, AJ ;
Frank, JI ;
Kay, R ;
Misch, D ;
Hill, C .
NEUROLOGY, 1998, 50 (03) :619-625
[3]   Quality improvement and tissue-type plasminogen activator for acute ischemic stroke - A Cleveland update [J].
Katzan, IL ;
Hammer, MD ;
Furlan, AJ ;
Hixson, ED ;
Nadzam, DM .
STROKE, 2003, 34 (03) :799-800